Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism
Public ClinicalTrials.gov record NCT01270841. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Placebo and Active Controlled, Parallel, Multi-Center Phase IIb Study to Evaluate Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Purpose of the study is to determine the effects of Androxal on morning testosterone and reproductive status in men with secondary hypogonadism(confirmed morning Testosterone less than 250 ng/dL), compared to changes with placebo, or Testim (topical testosterone). The effects of Testim versus placebo on reproductive status will also be examined. Study subjects must not be currently using a topical testosterone.
Study identification
- NCT ID
- NCT01270841
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 83 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 65 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2010
- Primary completion
- Nov 30, 2011
- Completion
- Nov 30, 2011
- Last update posted
- Jul 27, 2014
2011
United States locations
- U.S. sites
- 18
- U.S. states
- 4
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Paradigm Clinical Inc. | Garden Grove | California | 92844 | — |
| Northern California Research Corp | Sacramento | California | 95831 | — |
| Medical Center for Clinical Research | San Diego | California | 92108 | — |
| Los Angeles Biomedical Research Institute | Torrance | California | 90502 | — |
| Affiliated Clinical Research | Las Vegas | Nevada | 89109 | — |
| Affiliated Clinical Research Inc. | Las Vegas | Nevada | 89144 | — |
| Weill Cornell Medical College and Smith Institute | Great Neck | New York | 11021 | — |
| Jed Kaminetsky | New York | New York | 10016 | — |
| Natan Bar-Chama | New York | New York | 10022 | — |
| Michael A Werner | Purchase | New York | 10577 | — |
| Discovery Clinical Trials | Austin | Texas | 78758 | — |
| Research Across America | Carrollton | Texas | 75010 | — |
| Texas Urology Specialist | Houston | Texas | 77024 | — |
| Centex Research | Houston | Texas | 77062 | — |
| Endocrine and Psychiatry Center | Houston | Texas | 77095 | — |
| Protenium Clinical Research | Hurst | Texas | 76054 | — |
| R/D Clinical Research | Lake Jackson | Texas | 77566 | — |
| Cetero Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01270841, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2014 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01270841 live on ClinicalTrials.gov.